Johnson & Johnson wins FDA IDE for Ottava surgical robot
November 12, 2024
Johnson & Johnson MedTech announced today that the FDA granted its Ottava surgical robot investigational device exemption (IDE).
Johnson & Johnson MedTech announced today that the FDA granted its Ottava surgical robot investigational device exemption (IDE).
TEL AVIV, Israel and FORT LAUDERDALE, Fla., Nov. 11, 2024 /PRNewswire/ — Momentis Surgical Ltd., a leader in robotic-assisted surgical innovation, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for its second-generation Anovo® robotic surgical platform.
Corin announced that it received FDA 510(k) clearance for its Icona femoral stem implant for total hip arthroplasty (THA).
Distalmotion announced today that it received FDA de novo approval for its Dexter surgical robot for adult inguinal hernia repair.
MOUNTAIN VIEW, Calif., Oct. 24, 2024 /PRNewswire/ — In a groundbreaking advancement for medical science, surgeons in Santiago, Chile, performed the world’s first robotic surgeries combining 3D visualization and augmented reality (AR), marking a significant step forward in improving surgical speed, visualization, precision, and patient outcomes.
Momentis Surgical (formerly Memic) announced today that it received FDA 510(k) clearance for its Anovo robotic surgical platform.
CMR Surgical announced today that it received FDA de novo clearance to market its Versius surgical robot platform.
Regenity Biosciences announced that it received FDA 510(k) clearance for its RejuvaKnee implant for soft tissue injuries of the meniscus.
Procept BioRobotics (Nasdaq:PRCT) announced today that the FDA approved an investigational device exemption (IDE) trial for its Aquablation therapy.
Corin announced that it received FDA 510(k) clearance for its Unity Knee medial constrained (MC) tibial insert.